Premium
How to prevent proliferative vitreoretinopathy ?
Author(s) -
JONAS JB
Publication year - 2012
Publication title -
acta ophthalmologica
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.534
H-Index - 87
eISSN - 1755-3768
pISSN - 1755-375X
DOI - 10.1111/j.1755-3768.2012.1554.x
Subject(s) - proliferative vitreoretinopathy , tamponade , vitrectomy , medicine , retinal detachment , ophthalmology , retinal , complication , pedf , triamcinolone acetonide , retinal pigment epithelium , retina , surgery , visual acuity , biology , neuroscience
Purpose Proliferative vitreoretinopathy (PVR) is a serious complication of any rhegmatogenous retinal detachment. Methods Besides an early intervention to close the retinal defect by either an episcleral buckling procedure or by vitrectomy and internal tamponade, additional medical regimens may be sought after to prevent the proliferation of intravitreally intruded retinal pigment epithelium cells and other cells. Results Itravitreal medical therapy, including drugs such as triamcinolone, microplasmin or anti‐VEGF drugs ma ybe discussed for their rol ein the prevention of PVR. Conclusion Potential procedures to reduce the risk of PVR will be discussed.